Where does Parallel Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Parallel Bio's 2 recorded funding rounds.

Premier Alternatives

Parallel Bio

Drug Discovery · Cambridge, MA · Founded 2020 · Privately Held (backing)

Operator of a biotechnology company intended to design and engineer tools to change the way diseases are cured. Parallel Bio is based in Cambridge, MA and was founded in 2020. It was valued at $71.5 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $24.6 million across 2 recorded rounds; the latest was a $20 million Series A1 in Jun 2025.

PMV mark · valuation

$71.5M

Oct 2026

Priced at

its later-stage round

Jun 2025

Total raised

$24.6M

Last round

Later Stage VC (Series A1)

Jun 2025

Cap table — not yet on record

Parallel Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Parallel Bio with a free account

·The complete investor list: 24 names
·Watch Parallel Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Parallel Bio

Where does Parallel Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Parallel Bio's 2 recorded funding rounds.